Cargando…

CASE SERIES OF PATIENTS UNDER BIWEEKLY TREATMENT WITH LARONIDASE: A REPORT OF A SINGLE CENTER EXPERIENCE

OBJECTIVE: To report the stabilization of urinary glycosaminoglicans (GAG) excretion and clinical improvements in patients with mucopolysaccharidosis type I (MPS I) under an alternative dose regimen of laronidase of 1.2 mg/kg every other week. METHODS: We participated in a dose-optimization trial fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kyosen, Sandra Obikawa, Toma, Leny, Nader, Helena Bonciani, Braga, Marion Coting, Pereira, Vanessa Gonçalves, Canossa, Sueli, Pesquero, João Bosco, D’Almeida, Vânia, Martins, Ana Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade de Pediatria de São Paulo 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868559/ https://www.ncbi.nlm.nih.gov/pubmed/31090850 http://dx.doi.org/10.1590/1984-0462/;2019;37;3;00010

Ejemplares similares

A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report
por: Gomes, Caio Perez, et al.
Publicado: (2020)

Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series
por: Horovitz, Dafne Dain Gandelman, et al.
Publicado: (2016)

Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships
por: Al-Sannaa, Nouriya A., et al.
Publicado: (2015)

Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts
por: Vicente, Carolina Meloni, et al.
Publicado: (2013)

The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis()
por: Dualibi, Ana Paula Fiuza Funicello, et al.
Publicado: (2015)

Lysosomal Acid Lipase Deficiency: Report of Five Cases across the Age Spectrum
por: Curiati, Marco Antonio, et al.
Publicado: (2018)

Oxidative stress assessment by glutathione peroxidase activity and glutathione levels in response to selenium supplementation in patients with Mucopolysaccharidosis I, II and VI
por: de Oliveira-Silva, José Araújo, et al.
Publicado: (2019)

Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
por: Giugliani, Roberto, et al.
Publicado: (2017)

Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes
por: Lund, Troy C., et al.
Publicado: (2019)

Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation
por: Polgreen, Lynda E., et al.
Publicado: (2019)

Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2017)

Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS)
por: Spataro, Federico, et al.
Publicado: (2022)

Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights
por: Martins, Ana Maria, et al.
Publicado: (2018)

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
por: Chon, Hong Jae, et al.
Publicado: (2011)

Data from subjects receiving intrathecal laronidase for cervical spinal stenosis due to mucopolysaccharidosis type I
por: Dickson, P.I., et al.
Publicado: (2015)

Safety of biweekly α(1)-antitrypsin treatment in the RAPID programme
por: Greulich, Timm, et al.
Publicado: (2018)

Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior
por: da Silva, Flávia Helena, et al.
Publicado: (2012)

Heparan Sulfate Proteoglycans in Human Colorectal Cancer
por: Vicente, Carolina Meloni, et al.
Publicado: (2018)

Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease
por: Hsu, Yu-Hone, et al.
Publicado: (2017)

Posterior scleritis after biweekly aflibercept intravitreal injections
por: Hébert, Mélanie, et al.
Publicado: (2022)

SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells
por: Vicente, Carolina M, et al.
Publicado: (2015)

Multicenter, non-interventional, double cohort study to assess the safety of alglucosidase alfa and laronidase in real-world home infusion setting
por: Toscano, Antonio, et al.
Publicado: (2022)

Real-world data assessment of safety of home-based and hospital/outpatient-based laronidase enzyme replacement therapy for mucopolysaccharidosis I
por: Wilson, Amanda, et al.
Publicado: (2021)

Apoptosis status and proliferative activity in mucopolysaccharidosis type I mice tongue mucosa cells
por: Noguti, Juliana, et al.
Publicado: (2012)

Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex
por: Viana, Gustavo Monteiro, et al.
Publicado: (2020)

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer
por: Korkeila, E. A., et al.
Publicado: (2017)

The Underexploited Role of Non-Coding RNAs in Lysosomal Storage Diseases
por: de Queiroz, Matheus Trovão, et al.
Publicado: (2016)

Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients
por: Varela, Patrícia, et al.
Publicado: (2020)

Functional and molecular evidence for heteromeric association of P2Y(1) receptor with P2Y(2) and P2Y(4) receptors in mouse granulocytes
por: Ribeiro-Filho, Antonio Carlos, et al.
Publicado: (2016)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS)
por: Vultaggio, Alessandra, et al.
Publicado: (2018)

Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory: Erratic symptoms or scores?
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy
por: Schirwani-Hartl, Nawa, et al.
Publicado: (2023)

Reference values for lysosomal enzymes activities using dried blood spots samples - a Brazilian experience
por: Müller, Karen B, et al.
Publicado: (2010)

Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients
por: Müller, Karen B., et al.
Publicado: (2012)

Novel GLA Mutation Promotes Intron Inclusion Leading to Fabry Disease
por: Varela, Patrícia, et al.
Publicado: (2019)

Sustained Levels of FGF2 Maintain Undifferentiated Stem Cell Cultures with Biweekly Feeding
por: Lotz, Steven, et al.
Publicado: (2013)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Sukari, Ammar, et al.
Publicado: (2015)

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801
por: Takayama, Koichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ash4f6sn1olmncv4s72o2vfr7